SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001824293-22-000050
Filing Date
2022-06-10
Accepted
2022-06-10 08:30:24
Documents
4
Period of Report
2022-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxannualmeetingresults.htm 8-K 35659
2 GRAPHIC image_0a.jpg GRAPHIC 16879
3 GRAPHIC image_8a.jpg GRAPHIC 1656
4 GRAPHIC logo_filings1a.jpg GRAPHIC 95792
  Complete submission text file 0001824293-22-000050.txt   194597
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40034 | Film No.: 221007701
SIC: 2834 Pharmaceutical Preparations